The U.S. Food and Drug Administration (FDA) inspects both 503A and 503B compounding pharmacies to assess if procedures, practices and controls exist for the preparation of products in compliance with FDA requirements. Are you prepared? Join Eagle Analytical Services General Manager and Chief Technical Officer Ross Caputo, PhD, for this FREE webinar, which will help you understand the inspections procedure, provide detailed information regarding the areas in which investigators are trained to evaluate, and outline the inspection process and expectations from the FDA. The information is not intended to convey legal advice; its sole use is for educational purposes.
Eagle is an FDA and DEA registered, A2LA ISO 17025 accredited laboratory providing analytical and microbiological testing services along with expert consulting services to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies.
Latest posts by Eagle Analytical (see all)
- Central Drug Compounding & Wellness Recommends Eagle Plates - April 16, 2021
- Paperless Sample Submissions – Effective May 3, 2021 - April 8, 2021
- The Woodlands Compounding Pharmacy Recommends Eagle Plates - April 7, 2021
